ArticleAnais brasileiros de dermatologia

Risankizumab and guselkumab for psoriasis: a 1-year real-world practice indirect comparison.

Leyla Baykal Selçuk et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.